Table 2.
Surface phenotype of CD8+ T-cell clones
%Positive | Day 8* |
Day 15* |
Day 22* |
||||||
---|---|---|---|---|---|---|---|---|---|
Treg | Non Treg | p-Value | Treg | Non Treg | p-Value | Treg | Non Treg | p-Value | |
CD11a | 100±0 | 100±0 | n.a. | 100±0 | 100±0 | n.a. | 100±0 | 100±0 | n.a. |
CD18 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 100±0 | 100±0 | n.a. |
CD69 | 41±16 | 57±37 | 0.45 | 61±19 | 81±16 | 0.16 | 69±13 | 81±17 | 0.33 |
CD16 | 0.7±0.2 | 2.0±2.4 | 0.33 | 0.2±0.1 | 1.1±1.2 | 0.17 | 0.5±0.1 | 1.2±0.7 | 0.10 |
CD161 | 13±23 | 7.6±12 | 0.71 | 15±28 | 8.2±13 | 0.67 | 18±33 | 12±17 | 0.74 |
CD56 | 45±28 | 25±16 | 0.25 | 50±30 | 34±25 | 0.43 | 56±28 | 30±23 | 0.19 |
(CD56+ MFI)** | (27±13) | (13±2) | (0.06) | (16±7) | (8±3) | (0.09) | (17±7) | (7±2) | (<0.05) |
CD62L | 45±25 | 50±33 | 0.83 | 6.7±11 | 7.5±9.0 | 0.91 | 3.7±5.1 | 4.5±4.5 | 0.82 |
CD95 | 49±19 | 61±22 | 0.43 | 14±4.8 | 30±24 | 0.25 | 10±6.2 | 23±16 | 0.19 |
CD27 | 0.5±0.1 | 2.2±3.0 | 0.30 | 1.1±0.4 | 1.1±0.8 | 0.96 | 1.5±0.9 | 1.3±1.0 | 0.86 |
CD28 | 0.4±0.2 | 4.3±5.3 | 0.19 | 0.2±0.1 | 0.7±0.8 | 0.24 | 1.0±0.3 | 2.2±2.1 | 0.31 |
CD122 | 4.7±3.6 | 3.5±2.7 | 0.63 | 0.6±0.2 | 1.4±1.1 | 0.23 | 1.9±0.3 | 3.2±1.9 | 0.25 |
CXCR4 | 1.0±0.6 | 4.7±6.3 | 0.27 | 0.1±0.1 | 0.3±0.2 | 0.14 | 0.6±0.4 | 1.1±0.9 | 0.35 |
CCR7 | 5.7±1.6 | 12±9.1 | 0.24 | 3.1±1.4 | 4.3±2.1 | 0.39 | 5.2±1.0 | 3.8±1.8 | 0.22 |
CD8+ Treg-cell clones: 1B3, 1E2, 1E8, and 1F3; non-Treg-cell clones: 1B1, 1B6, 1F1, and 1D1.
, CD8+ T-cell clones were analyzed 8, 15 and 22 days after PHA stimulation in the presence of feeder cells:
MFI of CD56 positive subsets; n.a., not available. The results are shown as percentage of positive cells (mean±SD).